Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients
- Registration Number
- NCT02218398
- Lead Sponsor
- Beijing Chao Yang Hospital
- Brief Summary
Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.
- Detailed Description
Bronchodilator is commonly used in mechanical ventilated chronic obstructive pulmonary disease patients. It is assumed that patient's response to bronchodilator is the same during acute exacerbation or when stable whether on mechanical ventilation or not. Decision to treat is often independent of response and the patient's response to the medicine is not precisely evaluated. Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
should meet all the criteria:
- Acute exacerbated chronic obstructive pulmonary disease
- Invasive mechanical ventilation with intubation outside ICU no more than 48 hours
Meet any of the criteria:
- Asthma
- Tracheotomy
- Prolonged Mechanical Ventilation (Have been mechanical ventilated for more than 21 days)
- Unstable hemodynamic status
- Severe pneumonia
- Contraindication for bronchodilator
- Contraindication for sedation
- Refusal to participate in study
- Re-intubation in 48 hours
- Mental disorder, could not understand and accomplish pulmonary function test
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Bronchodilator Albuterol Albuterol 3-4 times per day, steroids when necessary.
- Primary Outcome Measures
Name Time Method Percentage of 12% Decrease in airway resistance 30 minutes
- Secondary Outcome Measures
Name Time Method Duration of mechanical ventilation participants will be followed for the duration of ICU stay, an expected average of 28 days
Trial Locations
- Locations (1)
Respiratory Intensive Care Unit, Beijing Chaoyang Hospital
🇨🇳Beijing, Beijing, China